<p>Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN<sup>®</sup>) and Follow-Up Considerations/Recommendations</p> | Publicación